These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 11183352)

  • 1. Chinese herbs and urothelial carcinoma.
    Shum S
    N Engl J Med; 2000 Oct; 343(17):1268-9; author reply 1269-70. PubMed ID: 11183352
    [No Abstract]   [Full Text] [Related]  

  • 2. Chinese herbs and urothelial carcinoma.
    Lu W; Lu W
    N Engl J Med; 2000 Oct; 343(17):1269; author reply 1269-70. PubMed ID: 11183353
    [No Abstract]   [Full Text] [Related]  

  • 3. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi).
    Nortier JL; Martinez MC; Schmeiser HH; Arlt VM; Bieler CA; Petein M; Depierreux MF; De Pauw L; Abramowicz D; Vereerstraeten P; Vanherweghem JL
    N Engl J Med; 2000 Jun; 342(23):1686-92. PubMed ID: 10841870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chinese herbs and urothelial carcinoma.
    Li YM
    N Engl J Med; 2000 Oct; 343(17):1269; author reply 1269-70. PubMed ID: 11183354
    [No Abstract]   [Full Text] [Related]  

  • 5. Invasive urothelial carcinoma after exposure to Chinese herbal medicine containing aristolochic acid may occur without severe renal failure.
    Nortier JL; Schmeiser HH; Muniz Martinez MC; Arlt VM; Vervaet C; Garbar CH; Daelemans P; Vanherweghem JL
    Nephrol Dial Transplant; 2003 Feb; 18(2):426-8. PubMed ID: 12543902
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk.
    Su YC; Lin JS; Lee MT; Li TC; Lee SM
    J Natl Cancer Inst; 2010 Jul; 102(13):988; author reply 988-90. PubMed ID: 20479292
    [No Abstract]   [Full Text] [Related]  

  • 7. Cancer and herbs.
    Kessler DA
    N Engl J Med; 2000 Jun; 342(23):1742-3. PubMed ID: 10841878
    [No Abstract]   [Full Text] [Related]  

  • 8. Urothelial malignancy in nephropathy due to Chinese herbs.
    Cosyns JP; Jadoul M; Squifflet JP; Van Cangh PJ; van Ypersele de Strihou C
    Lancet; 1994 Jul; 344(8916):188. PubMed ID: 7912776
    [No Abstract]   [Full Text] [Related]  

  • 9. Chinese herbal nephropathy and urothelial malignancy.
    Mason RG; Donaldson D
    J R Soc Promot Health; 2002 Dec; 122(4):266-7. PubMed ID: 12557737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chinese herbs containing aristolochic acid associated with renal failure and urothelial carcinoma: a review from epidemiologic observations to causal inference.
    Yang HY; Chen PC; Wang JD
    Biomed Res Int; 2014; 2014():569325. PubMed ID: 25431765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case reports--disparaging herbal drugs?
    Krenn L;
    Phytomedicine; 2002 Dec; 9(8):763. PubMed ID: 12587701
    [No Abstract]   [Full Text] [Related]  

  • 12. Alternative medicine. Herbal product linked to cancer.
    Greensfelder L
    Science; 2000 Jun; 288(5473):1946. PubMed ID: 10877707
    [No Abstract]   [Full Text] [Related]  

  • 13. DNA damage in cytologically normal urothelial cells of patients with a history of urothelial cell carcinoma.
    Gontijo AM; Marcondes JP; Elias FN; de Oliveira ML; de Lima RO; Salvadori DM; de Camargo JL
    Environ Mol Mutagen; 2002; 40(3):190-9. PubMed ID: 12355553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polypoid/papillary cystitis: a series of 41 cases misdiagnosed as papillary urothelial neoplasia.
    Lane Z; Epstein JI
    Am J Surg Pathol; 2008 May; 32(5):758-64. PubMed ID: 18379418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herbal medicine might be responsible for high incidence of urinary tract cancer.
    Hawkes N
    BMJ; 2012 Apr; 344():e2644. PubMed ID: 22496145
    [No Abstract]   [Full Text] [Related]  

  • 16. Significance of denuded urothelium in papillary urothelial lesions.
    Owens CL; Epstein JI
    Am J Surg Pathol; 2007 Feb; 31(2):298-303. PubMed ID: 17255776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular changes in development and progression of urothelial carcinoma].
    Hartmann A
    Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesteryl ester detection in a human urothelial carcinoma.
    Tugnoli V; Tosi MR
    Clin Chim Acta; 2005 Oct; 360(1-2):208-10. PubMed ID: 15979063
    [No Abstract]   [Full Text] [Related]  

  • 19. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
    Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
    Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of four Chinese herbal extracts on drug-sensitive and multidrug-resistant small-cell lung carcinoma cells.
    Sadava D; Ahn J; Zhan M; Pang ML; Ding J; Kane SE
    Cancer Chemother Pharmacol; 2002 Apr; 49(4):261-6. PubMed ID: 11914903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.